The INNOPHARMA Drug Screening and Pharmacogenomics Platform arises from the BioFarma group's accumulated experience of more than 20 years in continuing programs, testing hundreds of thousands of compounds, tens of targets and the development, automation and implementation of hundreds of assays in complete cascades of early drug discovery.
The high-capacity infrastructures owned by INNOPHARMA allow it to be a European reference in early drug discovery, being accredited as one of the seven high-capacity nodes of the European Research Infrastructure Consortium (ERIC) EU-OPENSCREEN. INNOPHARMA Platform offers a set of services that cover all stages of the early drug discovery process from target identification to preliminary safety and toxicity assessment.
The platform is available for both on-demand services and complementary collaborative projects in drug discovery.
Company Details
- Address
- Cimus Building. Avenida De Barcelona, Floor 2,office 11,spain
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://innopharma.usc.es/
- Keywords
- Santiago de Compostela.
- HQ
- Santiago de Compostela, A Coruña
Innopharma Platform Questions
Innopharma Platform's website is https://innopharma.usc.es/
Innopharma Platform's LinkedIn profile is https://es.linkedin.com/company/innopharma-platform
Innopharma Platform's industry is
Research Services
Innopharma Platform's top competitors are
Kærtor Foundation,
Innerva Pharmaceuticals, S.l.,
Biofarma Research Group,
Amslab,
Biopolo Sionlla,
Startups.st,
Celtarys Research,
Innopharma, Inc.,
Cimus (Center For Research In Molecular Medicine And Chronic Diseases),
Ceamsa.
Innopharma Platform's categories are Research Services
